Terazid Tablet 5mg (Terazosin Hydrochloride Hydrate)

Adult dose

1. Urinary disorders due to benign prostatic hyperplasia - Initial dose: 1mg orally before bedtime as the initial dose as terazosin, and this dosage should not be exceeded. Carefully monitor the patient’s condition during initial administration. - Maintenance dose: Gradually increase the dosage until symptoms improve, with an oral administration of 5-10mg once daily. - When used in conjunction with diuretics and other antihypertensives, the dosage may be reduced and increased as needed. 2

This medicine is an alpha-blocker and should not be used in certain patients. First, it should not be administered to patients who have a history of allergy or hypersensitivity to this drug or similar medications, patients under 12 years of age, and those with lactose intolerance or certain genetic digestive disorders. Caution is required for patients with severely impaired liver or kidney function, patients with a history of orthostatic hypotension, cardiovascular diseases, diabetes, and other specific conditions. Additionally, patients allergic to the color additives in this drug should be careful. When taking this medicine, side effects such as dizziness or fainting may occur, so special caution should be taken when starting treatment or adjusting the dosage. If these symptoms arise, lie down immediately and seek medical assistance if necessary. Psychological symptoms may include depression, headache, drowsiness, etc., while cardiovascular abnormalities may include rapid heartbeat, edema, and chest pain. Various side effects such as liver dysfunction, indigestion, respiratory problems, urinary tract abnormalities, and sensory disturbances have also been reported. This drug is a treatment for urinary disorders; if it is ineffective, other treatment options should be considered. Additionally, since prostate cancer may present similar symptoms, it is essential to check for cancer status before treatment. Patients undergoing cataract surgery must inform their healthcare providers about taking this medication as it may change the surgical method due to the risk of specific ophthalmic complications during the surgery. While this drug has few special interactions when used alongside other medications, caution is needed when using it with blood pressure-lowering medications as the blood pressure-lowering effect may be enhanced. Women who are pregnant or breastfeeding should use this drug cautiously, as its safety has not been established. If possible, breastfeeding should be avoided during treatment or breastfeeding should be discontinued. The safety and effectiveness in children have not been confirmed, and elderly patients should start with a lower dosage to minimize the risk of blood pressure lowering. In cases of overdose, a rapid drop in blood pressure may occur, and immediate medical intervention is needed; this drug is not removed by dialysis. For storage, keep out of reach of children and do not transfer to other containers for safety purposes.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by high fever, blistering, peeling skin, painful oral or ocular mucous membranes, shortness of breath or difficulty breathing, asthma attack, respiratory difficulties with cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary retention

Mild side effects

• Depression
• irritability
• dizziness
• headache
• lethargy
• weakness
• sweating
• insomnia
• cold sensation
• shoulder stiffness

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It should be kept at room temperature, between 1 to 30 degrees Celsius, to maintain its effectiveness.

Appearance

Pale green round tablet

Package unit

30 tablets/bottle, 500 tablets/bottle